newsfilter
← Latest News
GlobeNewswire·

Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026

NEW HAVEN, Conn., July 28, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review